| |
HPV (+) N = 22
|
HPV (-) N = 5
|
p
|
|---|
|
Gender
| | |
0.1751a
|
|
Female
|
17
|
3
| |
|
Male
|
05
|
2
| |
|
Site of primary tumor
| | |
0.2386a
|
|
Anal Margin
|
3
|
-
| |
|
Anal Canal
|
15
|
5
| |
|
Anal Margin and Canal
|
3
|
3
| |
|
Lesion type
| | |
0.7809a
|
|
Ulceration
|
3
|
1
| |
|
Vegetating
|
2
|
-
| |
|
Ulceration and Vegetating
|
5
|
1
| |
|
Stenosing
|
1
|
-
| |
|
Non evaluated
|
10
|
06
| |
|
Size of the lesion (cm)
| | |
0.3657a
|
|
≤ 0.5
|
-
|
1
| |
|
0.6–2.0
|
6
|
2
| |
|
2.1–5.0
|
11
|
4
| |
|
≥ 5.1
|
03
|
-
| |
|
UJCC/TNM Staging
| | |
0.7542a
|
|
I
|
-
|
1
| |
|
II
|
2
|
-
| |
|
III
|
9
|
-
| |
|
IV
|
-
|
-
| |
|
Non evaluated
|
9
|
6
| |
|
Lymph node involvement
| | |
0.3133*
|
|
Yes
|
7
|
-
| |
|
No
|
11
|
5
| |
|
Non evaluated
|
2
|
2
| |
|
Inflammatory process
| | |
0.3017a
|
|
Yes
|
3
|
2
| |
|
No
|
12
|
2
| |
|
Non evaluated
|
6
|
4
| |
- Significant p values < 0.05
-
a Fisher’s test
- * Chi-square